Takeshi Kadokura

Title: The Innovations of Takeshi Kadokura

Introduction

Takeshi Kadokura is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anticoagulant compounds. With a total of 2 patents to his name, Kadokura's work is recognized for its potential impact on medical treatments.

Latest Patents

Kadokura's latest patents focus on substituted benzene derivatives or salts thereof. These compounds exhibit anticoagulant action by inhibiting activated blood coagulation factor X. They are useful as anticoagulants or preventive and therapeutic agents for diseases induced by thrombosis or embolism. The effective ingredients include compounds such as 4'-bromo-2′-[(5-chloro-2-pyridyl) carbamoyl]-6′-β-D-galactopyranosyloxy-1-isopropylpiperidine-4-carboxanilide and 2′-(2-acetamido-2-deoxy-β-D-glucopyranosyloxy)-4′-bromo-6′-[(5-chloro-2-pyridyl)carbamoyl]-1-isopropylpiperidine-4-carboxanilide, among others.

Career Highlights

Takeshi Kadokura is currently employed at Astellas Pharma GmbH, where he continues to innovate in the pharmaceutical industry. His work is characterized by a commitment to developing effective treatments that address critical health issues.

Collaborations

Kadokura collaborates with notable colleagues, including Tsukasa Ishihara and Fukushi Hirayama. Their combined expertise contributes to the advancement of research and development in their field.

Conclusion

Takeshi Kadokura's contributions to the field of pharmaceuticals through his innovative patents highlight his role as a key inventor in the industry. His work has the potential to significantly improve medical treatments for patients suffering from thrombosis and embolism.